Fabb Pharma Ltd
14924791
Healthy
No risk factors detected.
Details
Compliance
Last accounts
30/06/2024
unaudited abridged
Next accounts due
30/06/2026
Confirmation statement
Last: 07/06/2025
Due 21/06/2026
Industry
Officers
director · Since 08/06/2023
COMPANY DIRECTOR
BRITISH · ENGLAND · Age 32
Also on 1 other board
director · Since 08/06/2023
COMPANY DIRECTOR
GERMAN · ENGLAND · Age 38
Also on 5 other boards
Persons with Significant Control
Miss Fizza Tahir
German · England · Age 38
1, Bowler Place, Stockport, SK3 0BF
Notified 08/06/2023
Mr Ibrahim Abbadi
British · England · Age 32
1, Bowler Place, Stockport, SK3 0BF
Notified 08/06/2023
CompanyRankvs 3075+ SIC 47730 peers51
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/06/2025
Net Worth
£22k
Balance sheet strength
Cash
£26k
Cash in the bank
Net Current Assets
£5k
Working capital
Current Assets
£81k
Current Liabilities
£76k
Fixed Assets
£112k
Debtors
£45k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.07 | +£16k |
| 2024 | 1.42 | — |
Derived from filed accounts. Not audited figures.